2025-05-29 - Analysis Report
Okay, here's an analysis of Teladoc Health Inc (TDOC) based on the data you provided, presented in a report format with an emphasis on numbers first, followed by analysis.

## Teladoc Health Inc (TDOC) Analysis

**Company Overview:** Teladoc Health Inc. is a telehealth company that provides virtual healthcare services.

### 1. Performance vs. S&P 500 (VOO)

*   **TDOC Cumulative Return:** -69.94%
*   **VOO Cumulative Return:** 83.24%
*   **Absolute Divergence:** -153.2
*   **Divergence Range:** Max: 450.6, Min: -164.3
*   **Relative Divergence:** 1.8

**Analysis:** TDOC has significantly underperformed the S&P 500. The divergence is currently at -153.2. The relative divergence of 1.8 indicates that the current divergence is near the lower end of its historical range compared to the VOO.

### Alpha, Beta Analysis

| Year       | CAGR     | MDD      | Alpha    | Beta    | Cap(B)  |
| ---------- | -------- | -------- | -------- | ------- | ------- |
| 2015-2017  | 76.0%    | 60.6%    | 49.0%    | -0.0    | 6.2     |
| 2016-2018  | 128.0%   | 59.3%    | 110.0%   | 0.0     | 8.8     |
| 2017-2019  | 176.0%   | 59.3%    | 147.0%   | 0.4     | 14.9    |
| 2018-2020  | 237.0%   | 64.0%    | 211.0%   | 0.2     | 35.6    |
| 2019-2021  | -83.0%   | 64.0%    | -138.0%  | 0.2     | 16.4    |
| 2020-2022  | -295.0%  | 81.3%    | -301.0%  | 0.0     | 4.2     |
| 2021-2023  | -488.0%  | 81.3%    | -505.0%  | -0.6    | 3.8     |
| 2022-2024  | -111.0%  | 81.3%    | -128.0%  | -0.9    | 1.6     |
| 2023-2025  | -41.0%   | 72.9%    | -70.0%   | -0.8    | 1.2     |

**Analysis:**

*   **CAGR:**  The Compound Annual Growth Rate shows a dramatic shift from high growth in earlier periods to significant losses in recent years.
*   **MDD:**  The Maximum Drawdown indicates substantial risk and volatility, especially in recent periods.
*   **Alpha:**  Alpha is consistently negative in recent years, indicating underperformance relative to its benchmark.
*   **Beta:**  Beta values close to zero suggest low correlation with the market, but the recent negative beta suggests a slight inverse relationship.
*   **Cap(B):** Market Cap has decreased from 35.6B to 1.2B from 2018-2020 to 2023-2025

### 2. Recent Price Action

*   **Current Price:** $6.97
*   **Previous Close:** $7.08
*   **Change:** -1.55%
*   **5-day Moving Average:** 6.946
*   **20-day Moving Average:** 7.134
*   **60-day Moving Average:** 7.6847

**Analysis:**  The stock price is currently below its 20-day and 60-day moving averages, suggesting a short-term downward trend. The slight decrease from the previous close (-1.55%) contributes to the downtrend but is not a dramatic shift.

### 3. Technical Indicators and Expected Return

*   **Market Risk Indicator (MRI):** 0.366 (Low Risk)
*   **RSI:** 52.16
*   **PPO:** 0.0394
*   **Hybrid Signal:** cash_0%_Buy 50% of cash (1 shares - Caution - MRI:0.38) (Cash Ratio: 0% on 2025-05-06)
*   **Recent (20-day) Relative Divergence Change:** 0.0 (-), 단기하락
*   **Expected Return:** -5091.3%

**Analysis:**

*   The MRI indicates a "Low Risk" environment.
*   RSI is around 52, suggesting neither overbought nor oversold conditions.
*   The PPO is positive but low, indicating a slight bullish momentum.
*   The "Hybrid Signal" suggests a cautious buy recommendation, given the MRI.
*   The recent lack of change in relative divergence coupled with the price decrease indicates a recent short-term downtrend.
*   The extremely negative Expected Return suggests a very pessimistic outlook for TDOC compared to the S&P 500 over the long term.

### 4. Recent News & Significant Events

*   **[2025-05-29]:**  Major business developments, regulatory changes, or market events are influencing Teladoc Health Inc.
*   **[2025-05-27]:** Analysts are discussing Teladoc Health Inc's recent performance and its outlook in the context of industry trends and global economic factors.
*   **[2025-05-28]:**  Stock has shown notable volatility, influenced by recent news, earnings reports, or executive actions.
*   **[2025-05-25]:** Market experts highlight both risks and opportunities for Teladoc Health Inc, advising investors to monitor recent news and company announcements.

**Analysis:** The news snippets indicate recent volatility and the need to stay informed about company-specific developments and broader market trends affecting Teladoc Health.

### 5. Recent Earnings Analysis

| 날짜       | EPS    | 매출       |
| ---------- | ------ | ---------- |
| 2025-05-01 | -0.53  | 0.63 B$    |
| 2024-10-31 | -0.19  | 0.64 B$    |
| 2024-08-01 | -4.92  | 0.64 B$    |
| 2024-04-26 | -0.49  | 0.65 B$    |
| 2025-05-01 | -0.49  | 0.65 B$    |

**Analysis:**

*   The company has consistently reported negative EPS.
*   Revenue has been relatively stable around $0.63B - $0.65B.
*   The significant EPS loss in 2024-08-01 (-4.92) is a major concern, although it has slightly recovered.

### 6. Financial Information

**Revenue and Profitability:**

| Quarter      | Revenue   | Profit Margin |
| ----------- | -------- | ------------- |
| 2025-03-31 | $0.63B  | 68.73%        |
| 2024-12-31 | $0.64B  | 70.50%        |
| 2024-09-30 | $0.64B  | 71.94%        |
| 2024-06-30 | $0.64B  | 70.73%        |
| 2024-03-31 | $0.65B  | 69.89%        |

**Capital and Profitability:**

| Quarter      | Equity    | ROE        |
| ----------- | -------- | ----------- |
| 2025-03-31 | $1.43B  | -6.52%     |
| 2024-12-31 | $1.49B  | -3.25%     |
| 2024-09-30 | $1.51B  | -2.21%     |
| 2024-06-30 | $1.50B  | -55.77%    |
| 2024-03-31 | $2.29B  | -3.58%     |

**Analysis:**

*   **Revenue and Profitability:** While revenue is relatively stable, the profit margins are consistently positive, indicating that the company is generating profit on its sales.
*   **Capital and Profitability:** Equity has significantly decreased over the past year, signaling a decline in the company's net worth. ROE (Return on Equity) is consistently negative, indicating that the company is not generating profits from its equity.

### 7. Overall Analysis

Based on the provided data, Teladoc Health Inc. (TDOC) presents a mixed picture with a strong negative outlook:

*   **Underperformance:**  TDOC has significantly underperformed the S&P 500, with a large negative divergence.
*   **Financials:** Negative EPS and ROE, and decreasing equity, are major concerns.
*   **Technicals:**  Short-term downtrend is indicated by moving averages. The MRI being low is a positive but is outweighed by other negative indicators.
*   **News:** Recent news suggests volatility and the need for close monitoring of company-specific events.
*   **Expected Return:** The extremely negative expected return highlights the substantial risks associated with this investment compared to the S&P 500.
*   **Recommendation:** Based on this analysis, a very cautious approach is warranted. The "Hybrid Signal" indicates some buying potential.
